The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications.
第一作者:
Dinci,Pennap
第一单位:
Ms. Pennap, Dr. Burcu, and Dr. Zito are with the Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore. Dr. Zito is also with the Department of Psychiatry, University of Maryland, Baltimore. Dr. Safer is with the Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore.
作者:
主题词
青少年(Adolescent);抗精神病药(Antipsychotic Agents);儿童(Child);儿童, 学龄前(Child, Preschool);横断面研究(Cross-Sectional Studies);药物处方(Drug Prescriptions);女(雌)性(Female);人类(Humans);婴儿(Infant);男(雄)性(Male);Medicaid(Medicaid);精神障碍(Mental Disorders);中大西洋地区(Mid-Atlantic Region);药品标示外使用(Off-Label Use);同行评议, 卫生保健(Peer Review, Health Care);患病率(Prevalence);美国(United States)
DOI
10.1176/appi.ps.201700177
PMID
29137557
发布时间
2019-06-25
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文